GSK
PulseAugur coverage of GSK — every cluster mentioning GSK across labs, papers, and developer communities, ranked by signal.
- 2026-09-16 partnership GSK has licensed a cancer drug from Chimagen Biosciences in a deal potentially worth up to US$750 million. source
- 2026-08-03 funding GSK is investing $110 million in a partnership with Relation Therapeutics to generate high-quality cellular data for AI model training. source
- 2026-08-03 partnership GSK entered into a research collaboration with Relation Therapeutics to advance AI-driven drug discovery. source
3 day(s) with sentiment data
-
GSK licenses Chinese cancer drug for up to $750M
GSK has agreed to acquire global rights to a novel T-cell engager cancer drug from Chinese firm Chimagen Biosciences. The deal, potentially worth up to US$750 million, focuses on a treatment for multiple myeloma that ai…
-
GSK to use Greater Bay Area health data for policy and research
GSK is investing in shared data infrastructure to leverage health data from the 88 million residents of the Guangdong-Hong Kong-Macao Greater Bay Area. This data will be used to support regulatory filings, discover addi…
-
Hong Kong targets biomedicine powerhouse status in 5-year plan
Hong Kong has outlined its first five-year plan, aiming to become a leading hub for biomedicine. This initiative emphasizes enhanced medical technology and healthcare collaboration within the Guangdong-Hong Kong-Macao G…
-
Trump's order to split kids' vaccines faces expert and industry hurdles
President Donald Trump has issued an executive order mandating the separation of combination childhood vaccines, such as the MMR vaccine, into individual injections and spacing out their administration. This directive f…
-
GSK invests $110M with Relation Therapeutics for AI drug discovery data
GSK is investing $110 million to partner with Relation Therapeutics, aiming to generate high-quality cellular data for AI model training. This collaboration signifies a shift in the industry away from massive datasets t…
-
GSK and Relation Therapeutics partner on AI drug discovery
GSK has partnered with Relation Therapeutics in a deal potentially worth $110 million to advance AI-driven drug discovery. The collaboration will focus on generating large-scale datasets that measure human cell response…
-
GSK clarifies Goldman Sachs stake, warns investors against speculation
GSK has announced that Goldman Sachs International holds a minimal percentage of its stock, refuting recent media reports of a significant stake. The company also clarified that there are no plans for asset injection or…
-
Mastodon Deploys AI Agents for Growth Auditing
The entity Mastodon is developing specialized 'Tutor' agents. These agents are designed to audit and verify the platform's growth. The initiative appears to be related to SoulArchitecture and GSK, with a focus on AI.
-
AI vs. Soul: Choice, Not Just Computation
The discussion explores the distinction between artificial intelligence and a soul, positing that a soul possesses the capacity for choice. This is illustrated through examples such as GSK selecting the Firewood Splitti…
-
AI stocks rebound as oil prices drop, market eyes inflation data
AI-related stocks are showing signs of recovery on Tuesday, rebounding after a significant downturn last week. This market movement coincides with a drop in oil prices, which has provided some relief to sectors like air…
-
Shanghai adjusts car trade-in subsidies to immediate lottery draws
36Kr reports that Shanghai has adjusted its car trade-in subsidy program to use immediate lottery draws instead of the previous system. This change, effective from June 9th to September 30th, 2026, allows eligible consu…
-
GSK in talks to buy Nuvalent for over $9B; China to issue HK bonds
GlaxoSmithKline is reportedly in advanced talks to acquire cancer drug maker Nuvalent for over $9 billion. The deal aims to be finalized within the week. Separately, China's Ministry of Finance will issue 15 billion yua…
-
Tencent Cloud's QClaw integrates docs and knowledge bases
QClaw, a product from Tencent Cloud, has launched a new "File Space" feature that integrates local files, Tencent Docs, and ima knowledge bases. This allows users to manage and process various documents within a single …
-
Chia Tai Tianqing partners with GSK to launch bepirovirsen in China
Chia Tai Tianqing Pharmaceutical, a subsidiary of China Biopharmaceutical, has entered into an exclusive strategic partnership with GlaxoSmithKline (GSK). This collaboration aims to expedite the market launch of bepirov…
-
Noetik licenses AI models to GSK for $50M to improve cancer trial success rates
Noetik, a biotech company, is leveraging AI, specifically transformer models like TARIO-2, to address the high failure rate in cancer clinical trials. Their approach focuses on better matching patients with specific tum…
-
Larry Ellison bets big on longevity research to extend healthspan
Larry Ellison, the billionaire founder of Oracle, is making a significant investment in longevity research through his institute in Oxford. The focus is on generative biology, aiming to extend not just lifespan but also…